DXCM Financial Facts

Total operating expenses: 94.3M
Product cost of sales: 41.1M
See Full Income Statement

Total liabilities and stockholders' equity: 299.4M
Total assets: 299.4M
See Full Balance Sheet

DexCom, Inc. (DXCM) Earnings

  |   Expand Research on DXCM
Next EPS Date 8/5/16 *Est. EPS Growth Rate -35.3% *Last Qtr.
Average EPS % Beat Rate -145.4% Revenue Growth Rate +59.6% *Last Qtr.
Average % Move 1-Wk after EPS -0.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/27/16 Q116 -$0.23-$0.20 -$0.03$116.2M$110.38M N/A Details
2/23/16 Q415 $0.02$0.01 +$0.01$130.8M$123.74M N/A Details
11/4/15 Q315 -$0.07-$0.01 -$0.06$105.2M$99.88M N/A Details
8/5/15 Q215 -$0.05-$0.03 -$0.02$93.2M$84.81M N/A Details
4/29/15 Q115 -$0.17-$0.11 -$0.06$72.8M$71.32M N/A Details
2/25/15 Q414 $0.02-$0.03 +$0.05$84.3M$79.65M N/A Details
11/6/14 Q314 -$0.07-$0.06 -$0.01$69M$60.2M N/A Details
8/6/14 Q214 -$0.08-$0.10 +$0.02$58.8M$52.45M N/A Details